Intermittent explosive disorder

Pathophysiology

Impulsive behavior, and especially impulsive violence predisposition, have been correlated to a low brain serotonin turnover rate, indicated by a low concentration of 5-hydroxyindoleacetic acid (5-HIAA) in the cerebrospinal fluid (CSF). This substrate appears to act on the suprachiasmatic nucleus in the hypothalamus, which is the target for serotonergic output from the dorsal and median raphe nuclei playing a role in maintaining the circadian rhythm and regulation of blood sugar. A tendency towards low 5-HIAA may be hereditary. A putative hereditary component to low CSF 5-HIAA and concordantly possibly to impulsive violence has been proposed. Other traits that correlate with IED are low vagal tone and increased insulin secretion. A suggested explanation for IED is a polymorphism of the gene for tryptophan hydroxylase, which produces a serotonin precursor; this genotype is found more commonly in individuals with impulsive behavior.

IED may also be associated with damage or lesions in the prefrontal cortex, with damage to these areas, including the amygdala and hippocampus, increasing the incidences of impulsive and aggressive behavior and the inability to predict the outcomes of an individual's own actions. Lesions in these areas are also associated with improper blood sugar control, leading to decreased brain function in these areas, which are associated with planning and decision making. A national sample in the United States estimated that 16 million Americans may fit the criteria for IED.

EDS was associated with limbic system diseases, disorders of the temporal lobe, or abuse of alcohol or other psychoactive substances.

Diagnosis

DSM-5 diagnosis

The current DSM-5 criteria for Intermittent Explosive Disorder include:

• Recurrent outbursts that demonstrate an inability to control impulses, including either of the following:
  • Verbal aggression (tantrums, verbal arguments, or fights) or physical aggression that occurs twice in a week-long period for at least three months and does not lead to the destruction of property or physical injury (Criterion A1)
  • Three outbursts that involve injury or destruction within a year-long period (Criterion A2)
• Aggressive behavior is grossly disproportionate to the magnitude of the psychosocial stressors (Criterion B)
• The outbursts are not premeditated and serve no premeditated purpose (Criterion C)
• The outbursts cause distress or impairment of functioning or lead to financial or legal consequences (Criterion D)
• The individual must be at least six years old (Criterion E)
• The recurrent outbursts cannot be explained by another mental disorder and are not the result of another medical disorder or substance use (Criterion F)

It is important to note that DSM-5 now includes two separate criteria for types of aggressive outbursts (A1 and A2) which have empirical support:

• Criterion A1: Episodes of verbal and/or non-damaging, nondestructive, or non-injurious physical assault that occur, on average, twice weekly for three months. These could include temper tantrums, tirades, verbal arguments/fights, or assault without damage. This criterion includes high frequency/low-intensity outbursts.
• Criterion A2: More severe destructive/assaultive episodes which are more infrequent and occur, on average, three times within a twelve-month period. These could be destroying an object without regard to value or assaulting an animal or individual. This criterion includes high-intensity/low-frequency outbursts.

DSM-IV diagnosis

The past DSM-IV criteria for IED were similar to the current criteria, however, verbal aggression was not considered as part of the diagnostic criteria. The DSM-IV diagnosis was characterized by the occurrence of discrete episodes of failure to resist aggressive impulses that result in violent assault or destruction of property. Additionally, the degree of aggressiveness expressed during an episode should be grossly disproportionate to provocation or precipitating psychosocial stressor, and, as previously stated, diagnosis is made when certain other mental disorders have been ruled out, e.g., a head injury, Alzheimer's disease, etc., or due to substance use or medication. Diagnosis is made using a psychiatric interview to affective and behavioral symptoms to the criteria listed in the DSM-IV.

The DSM-IV-TR was very specific in its definition of Intermittent Explosive Disorder which was defined, essentially, by the exclusion of other conditions. The diagnosis required:

1. several episodes of impulsive behavior that result in serious damage to either persons or property, wherein
2. the degree of the aggressiveness is grossly disproportionate to the circumstances or provocation, and
3. the episodic violence cannot be better accounted for by another mental or physical medical condition.

EDS was a category in the Diagnostic and Statistical Manual of Mental Disorders (DSM IV). EDS may affect children or adults. Children are often considered to have epilepsy or a mental health problem. The episodes consist of recurrent attacks of uncontrollable rage, usually after minimal provocation, and may last up to an hour. Following an episode, children are frequently exhausted, may sleep and will usually have no recall.

Differential diagnosis

Many psychiatric disorders and some substance use disorders are associated with increased aggression and are frequently comorbid with IED, often making differential diagnosis difficult. Individuals with IED are, on average, four times more likely to develop depression or anxiety disorders, and three times more likely to develop substance use disorders. Bipolar disorder has been linked to increased agitation and aggressive behavior in some individuals, but for these individuals, aggression is limited to manic or depressive episodes, whereas individuals with IED experience aggressive behavior even during periods with a neutral or positive mood.

In one clinical study, bipolar and IED disorders co-occurred 60% of the time. Patients report manic-like symptoms occurring just before outbursts and continuing throughout. According to a study, the average onset age of IED was around five years earlier than the onset age of bipolar disorder, indicating a possible correlation between the two.

Similarly, alcoholism and other substance use disorders may exhibit increased aggression, but unless it is experienced outside of periods of acute intoxication and withdrawal, no diagnosis of IED is given. Studies suggest that childhood abuse and alcohol use disorder are linked to increased aggression and IED. For chronic disorders, such as post-traumatic stress disorder (PTSD), it is important to assess whether the level of aggression met IED criteria before the development of another disorder. In antisocial personality disorder (ASPD), interpersonal aggression is usually instrumental in nature (i.e., motivated by tangible rewards), whereas IED is more of an impulsive, unpremeditated reaction to situational stress.

Treatment

Although there is no cure, treatment is attempted through cognitive behavioral therapy and psychotropic medication regimens, though the pharmaceutical options have shown limited success. Therapy aids in helping the patient recognize the impulses in hopes of achieving a level of awareness and control of the outbursts, along with treating the emotional stress that accompanies these episodes. Multiple drug regimens are frequently indicated for IED patients. Cognitive Relaxation and Coping Skills Therapy (CRCST) has shown preliminary success in both group and individual settings compared to waitlist control groups. This therapy consists of 12 sessions, the first three focusing on relaxation training, then cognitive restructuring, then exposure therapy. The final sessions focus on resisting aggressive impulses and other preventative measures.

In France, antipsychotics such as cyamemazine, levomepromazine, and loxapine are sometimes used.

Tricyclic antidepressants and selective serotonin reuptake inhibitors (SSRIs, including fluoxetine, fluvoxamine, and sertraline) appear to alleviate some pathopsychological symptoms. Mood stabilizers and anticonvulsant drugs such as gabapentin, lithium, carbamazepine, and valproate seem to aid in controlling the incidence of outbursts. Anxiolytics help alleviate tension and may help reduce explosive outbursts by increasing the provocative stimulus tolerance threshold, and are especially indicated in patients with comorbid obsessive–compulsive disorder or other anxiety disorders.

Former treatments for EDS

Treatment for EDS usually involved treating the underlying causative factor(s). This may involve psychotherapy, or medical treatment for diseases.

EDS has been successfully controlled in clinical trials using prescribed medications, including carbamazepine, ethosuximide, and propranolol.

There have been few randomised controlled trials of treatment of EDS/IED. Antidepressants and mood stabilizers including lithium, valproate, and carbamazepine have been used in adults, and occasionally in children with oppositional defiant disorder or conduct disorder to reduce aggression. Cognitive behavioural therapy (CBT) is effective in the treatment of anger. A recent trial randomised adults with IED to 12 weeks of individual therapy, group therapy or waiting list (no therapy). Intervention resulted in an improvement in anger and aggression levels, with no difference between group and individual CBT. Adolescents and young adults may experience educational and social consequences, but also mental health problems if IED/EDS is undiagnosed in early childhood.

Epidemiology

Two epidemiological studies of community samples approximated the lifetime prevalence of IED to be 4–6%, depending on the criteria set used. A Ukrainian study found comparable rates of lifetime IED (4.2%), suggesting that a lifetime prevalence of IED of 4–6% is not limited to American samples. One-month and one-year point prevalences of IED in these studies were reported as 2.0% and 2.7%, respectively. Extrapolating to the national level, 16.2 million Americans would have IED during their lifetimes and as many as 10.5 million in any year and 6 million in any month.

Among a clinical population, a 2005 study found the lifetime prevalence of IED to be 6.3%.

Prevalence appears to be higher in men than in women.

Of US subjects with IED, 67.8% had engaged in direct interpersonal aggression, 20.9% in threatened interpersonal aggression, and 11.4% in aggression against objects. Subjects reported engaging in 27.8 high-severity aggressive acts during their worst year, with 2–3 outbursts requiring medical attention. Across the lifespan, the mean value of property damage due to aggressive outbursts was $1603.

A study in the March 2016 Journal of Clinical Psychiatry suggests a relationship between infection with the parasite Toxoplasma gondii and psychiatric aggression such as IED.

Legal implications

A diagnosis of EDS has been used as a defense in court for persons accused of committing violent crimes including murder.{{cite book | chapter-url-access = registration | chapter-url = https://archive.org/details/legaldefenseofpa00tiff/page/560

History

In the first edition of the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders (DSM-I), a disorder of impulsive aggression was referred to as a passive-aggressive personality type (aggressive type). This construct was characterized by a "persistent reaction to frustration are "generally excitable, aggressive, and over-responsive to environmental pressures" with "gross outbursts of rage or of verbal or physical aggressiveness different from their usual behavior".

In the third edition, the DSM-III, this was for the first time codified as intermittent explosive disorder and assigned clinical disorder status under Axis I. However, some researchers saw the criteria as poorly operationalized. About 80% of individuals who would now be diagnosed with the disorder would have been excluded.

In the DSM-IV, the criteria were improved but still lacked objective criteria for the intensity, frequency, and nature of aggressive acts to meet criteria for IED. This led some researchers to adopt alternate criteria set with which to conduct research, known as the IED-IR (Integrated Research). The severity and frequency of aggressive behavior required for the diagnosis were clearly operationalized, the aggressive acts were required to be impulsive in nature, subjective distress was required to precede the explosive outbursts, and the criteria allowed for comorbid diagnoses with borderline personality disorder and antisocial personality disorder.

In the current version, the DSM-5, the disorder appears under the "Disruptive, Impulse-Control, and Conduct Disorders" category. In the DSM-IV, physical aggression was required to meet the criteria for the disorder, but these criteria were modified in the DSM-5 to include verbal aggression and non-destructive/noninjurious physical aggression. The listing was also updated to specify frequency criteria. Further, aggressive outbursts are now required to be impulsive in nature and must cause marked distress, impairment, or negative consequences for the individual. Individuals must be at least six years old to receive the diagnosis. The text also clarified the disorder's relationship to other disorders such as attention deficit hyperactivity disorder (ADHD) and disruptive mood dysregulation disorder.

References

References

1. (1 June 2010). "Episodic dyscontrol syndrome". Archives of Disease in Childhood.
2. Elliott FA. (1984) The episodic dyscontrol syndrome and aggression. Neurologic Clinics 2: 113–25.
3. McElroy SL. (1999). "Recognition and treatment of DSM-IV intermittent explosive disorder". J Clin Psychiatry.
4. (April 1998). "DSM-IV intermittent explosive disorder: a report of 27 cases". J Clin Psychiatry.
5. Tamam, L., Eroğlu, M., Paltacı, Ö. (2011). "Intermittent explosive disorder". ''Current Approaches in Psychiatry'', '''3'''(3): 387–425.
6. (February 2024). "Personality Disorder Symptoms in Intermittent Explosive Disorder: A Latent Class Analysis". Journal of Personality Disorders.
7. (July 1995). "Low brain serotonin turnover rate (low CSF 5-HIAA) and impulsive violence". J Psychiatry Neurosci.
8. (June 2002). "Evidence for a dysfunctional prefrontal circuit in patients with an impulsive aggressive disorder". Proc. Natl. Acad. Sci. U.S.A..
9. Tebartz van Elst, Dr. L.. (February 2000). "Affective aggression in patients with temporal lobe epilepsy ''A quantitative MRI study of the amygdala''". Oxford University Press.
10. Drake ME, Hietter SA, Pakalnis A. (1992) EEG and evoked potentials in episodic-dyscontrol syndrome. Neuropsychobiology 26: 125–8.
11. Harbin HT. (1977) Episodic dyscontrol and family dynamics. American Journal of Psychiatry 134: 1113–6.
12. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
13. Coccaro, EF, Lee, R, & McCloskey, MF (2014). Validity of the new A1 and A2 criteria for DSM-5 intermittent explosive disorder. ''Comprehensive Psychology'', 55(2). {{doi. 10.1016/j.comppsych.2013.09.007.
14. (November 2016). "The cross-national epidemiology of DSM-IV intermittent explosive disorder". Psychological Medicine.
15. (1 June 2010). "Episodic dyscontrol syndrome". Archives of Disease in Childhood.
16. Nunn K. (1986) The episodic dyscontrol syndrome in childhood. Journal of Child Psychology and Psychiatry 27: 439–46.
17. Bach-y-Rita G, Lion JR, Climent CE, Ervin FR. (1971) Episodic (1986) dyscontrol: a study of 130 violent patients. American Journal of Psychiatry 127: 49–54.
18. Elliott FA. (1982) Neurological findings in adult minimal brain dysfunction and the dyscontrol syndrome. Journal of Nervous and Mental Disease 170: 680–7.
19. (1 June 2010). "Episodic dyscontrol syndrome". Archives of Disease in Childhood.
20. Coccaro, E.F. (2012). Intermittent explosive disorder as a disorder of impulsive aggression for DSM-5. "American Journal of Psychiatry," 169. 577-588.
21. Coccaro, EF (2000). Intermittent explosive disorder. ''Current Psychiatry Reports'', 2:67-71.
22. (2020-06-01). "History of childhood abuse and alcohol use disorder: Relationship with intermittent explosive disorder and intoxicated aggression frequency". Journal of Psychiatric Research.
23. Aboujaoude, E., & Koran, L. M. (2010). ''Impulsive control disorders''. Cambridge University Press: Cambridge.
24. McCloskey, M.S., Noblett, K.L., Deffenbacher, J.L, Gollan, J.K., Coccaro, E.F. (2008) Cognitive-Behavioral Therapy for Intermittent Explosive Disorder: A Pilot Randomized Clinical Trial. 76(5), 876-886.
25. Goodman, W. K., Ward, H., Kablinger, A., & Murphy, T. (1997). Fluvoxamine in the Treatment of Obsessive-Compulsive Disorder and Related Conditions. J Clin Psychiatry, 58(suppl 5), 32-49.
26. Dyscontrol]] with Mental Retardation. ''Am J Psychiatry'', 158(6), 965.
27. Coccaro EF, et al. "A Double-Blind, Randomized, Placebo-Controlled Trial of Fluoxetine in Patients With Intermittent Explosive Disorder," ''Journal of Clinical Psychiatry'' (April 21, 2009): Vol. 70, No. 5, pp. 653–62.
28. (1 June 2010). "Episodic dyscontrol syndrome". Archives of Disease in Childhood.
29. Tunks ER, Dermer SW. (1977) Carbamazepine in the dyscontrol syndrome associated with limbic system dysfunction. Journal of Nervous and Mental Disease 164: 56–63.
30. Lewin J, Sumners D. (1992) Successful treatment of episodic dyscontrol with carbamazepine. British Journal of Psychiatry 161: 261–2.
31. Andrulonis PA, Donnelly J, Glueck BC, Stroebel CF, Szarek BL. (1990) Preliminary data on ethosuximide and the episodic dyscontrol syndrome. American Journal of Psychiatry 137: 1455–6.
32. Grizenko N, Vida S. (1988) Propranolol treatment of episodic dyscontrol and aggressive behaviour in children. Canadian Journal of Psychiatry 33: 776–8.
33. (1 June 2010). "Episodic dyscontrol syndrome". Archives of Disease in Childhood.
34. (June 2006). "The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication". Arch. Gen. Psychiatry.
35. Coccaro EF, Schmidt CA, Samuels JF et al. Lifetime and one-month prevalence rates of intermittent explosive disorder in a community sample. J Clin Psychiatry 65:820–824, 2004.
36. Bromet EJ, Gluzman SF, Paniotto VI et al. Epidemiology of psychiatric and alcohol disorders in Ukraine: Findings from the Ukraine World Mental Health survey. Soc Psychiatry Psychiatr Epidemiol 40:681–690, 2005.
37. (October 2005). "Prevalence and features of intermittent explosive disorder in a clinical setting". J Clin Psychiatry.
38. Boyd, Mary Ann. (2008). "Psychiatric nursing: contemporary practice". Wolters Kluwer Health/Lippincott Williams & Wilkins.
39. Coccaro EF, Lee R, Groer MW, Can A, Coussons-Read M, Postolache TT (March 2016). [http://www.psychiatrist.com/jcp/article/Pages/2016/v77n03/v77n0313.aspx "''Toxoplasma gondii'' Infection: Relationship With Aggression in Psychiatric Subjects"] {{webarchive. link. (2016-03-24 . ''[[J Clin Psychiatry]]'' '''77'''(3): 334–341.)
40. Myers WC, Vondruska MA. (1998) Murder, minors, selective serotonin reuptake inhibitors, and the involuntary intoxication defence. Journal of the American Academy of Psychiatry and the Law 26: 487–96.
41. Felthous et al., 1991
42. Coccaro et al., 1998
43. (2013). "Highlights of Changes from DSM-IV-TR to DSM-5".